167 related articles for article (PubMed ID: 9326762)
21. High-Risk Corneal Graft Rejection in the Setting of Previous Corneal Herpes Simplex Virus (HSV)-1 Infection.
Kuffova L; Knickelbein JE; Yu T; Medina C; Amescua G; Rowe AM; Hendricks RL; Forrester JV
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1578-87. PubMed ID: 27050878
[TBL] [Abstract][Full Text] [Related]
22. Cytokine mRNA in BALB/c mouse corneas infected with herpes simplex virus.
Hu M; Dutt J; Arrunategui-Correa V; Baltatzis S; Foster CS
Eye (Lond); 1999 Jun; 13 ( Pt 3a)():309-13. PubMed ID: 10624423
[TBL] [Abstract][Full Text] [Related]
23. PEDF Reduces the Severity of Herpetic Simplex Keratitis in Mice.
Tian X; Wang T; Zhang S; Wang Q; Hu X; Ge C; Xie L; Zhou Q
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2923-2931. PubMed ID: 30025136
[TBL] [Abstract][Full Text] [Related]
24. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.
Bauer D; Lu M; Wasmuth S; Li H; Yang Y; Roggendorf M; Steuhl KP; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):216-25. PubMed ID: 16047184
[TBL] [Abstract][Full Text] [Related]
26. Lornoxicam suppresses recurrent herpetic stromal keratitis through down-regulation of nuclear factor-kappaB: an experimental study in mice.
Yin J; Huang Z; Xia Y; Ma F; Zhang LJ; Ma HH; Li Wang L
Mol Vis; 2009 Jun; 15():1252-9. PubMed ID: 19547717
[TBL] [Abstract][Full Text] [Related]
27. [Battle with herpes for 37 years].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis.
Xia L; Zhang S; Cao Z; Hu Y; Yang H; Wang D
Microbes Infect; 2013 Feb; 15(2):126-39. PubMed ID: 23159245
[TBL] [Abstract][Full Text] [Related]
29. A novel rare sugar inhibitor of murine herpes simplex keratitis.
Muniruzzaman S; McIntosh M; Hossain A; Izumori K; Bhattacharjee PS
J Pharmacol Sci; 2016 Jun; 131(2):126-30. PubMed ID: 27262904
[TBL] [Abstract][Full Text] [Related]
30. Herpes keratitis.
Rowe AM; St Leger AJ; Jeon S; Dhaliwal DK; Knickelbein JE; Hendricks RL
Prog Retin Eye Res; 2013 Jan; 32():88-101. PubMed ID: 22944008
[TBL] [Abstract][Full Text] [Related]
31. Macrophage-depletion influences the course of murine HSV-1 keratitis.
Bauer D; Mrzyk S; van Rooijen N; Steuhl KP; Heiligenhaus A
Curr Eye Res; 2000 Jan; 20(1):45-53. PubMed ID: 10611714
[TBL] [Abstract][Full Text] [Related]
32. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
33. Enhanced detection of herpes simplex virus from ocular specimens of herpetic keratitis patients.
Pramod NP; Gopalakrishnan V; Mohan R; Chandriga S; Anandakannan K; Menon T; Thyagarajan SP
Indian J Pathol Microbiol; 1998 Jan; 41(1):49-53. PubMed ID: 9581077
[TBL] [Abstract][Full Text] [Related]
34. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
[TBL] [Abstract][Full Text] [Related]
35. Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis.
Bauer D; Wasmuth S; Hennig M; Baehler H; Steuhl KP; Heiligenhaus A
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3188-98. PubMed ID: 19255156
[TBL] [Abstract][Full Text] [Related]
36. Anti-herpetic and anti-inflammatory activities of two new synthetic 22,23-dihydroxylated stigmastane derivatives.
Michelini FM; RamÃrez JA; Berra A; Galagovsky LR; Alché LE
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):111-6. PubMed ID: 18619833
[TBL] [Abstract][Full Text] [Related]
37. Viral replication is required for induction of ocular immunopathology by herpes simplex virus.
Babu JS; Thomas J; Kanangat S; Morrison LA; Knipe DM; Rouse BT
J Virol; 1996 Jan; 70(1):101-7. PubMed ID: 8523513
[TBL] [Abstract][Full Text] [Related]
38. Application of FGF-2 to modulate herpetic stromal keratitis.
Kim B; Lee S; Kaistha SD; Rouse BT
Curr Eye Res; 2006 Dec; 31(12):1021-8. PubMed ID: 17169840
[TBL] [Abstract][Full Text] [Related]
39. A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice.
Miller JK; Laycock KA; Umphress JA; Hook KK; Stuart PM; Pepose JS
Cornea; 1996 Sep; 15(5):497-504. PubMed ID: 8862927
[TBL] [Abstract][Full Text] [Related]
40. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N
Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
